.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Agriculture is evolving with the introduction of the fendioxypyracil herbicide, a novel systemic tool for weed management. This compound targets protoporphyrinogen oxidase (PPO), an enzyme essential for chlorophyll and heme biosynthesis. Because it addresses herbicide-resistant weeds, this next-generation chemical represents a significant shift in on-farm management. Furthermore, its unique pyridine-based core enhances binding affinity, making it more potent than existing options like saflufenacil.
Research confirms that this compound inhibits both PPO1 and PPO2 isoforms in plants. This chemical inhibition prevents the conversion of protoporphyrinogen IX into protoporphyrin IX. Consequently, the accumulation of reactive oxygen species leads to rapid tissue necrosis and plant death. Although it primarily targets weeds, the PPO enzyme also plays a role in human heme synthesis. Therefore, medical toxicologists and pharmacists must stay informed about these new agrochemicals to manage potential environmental exposure risks.
Recent field trials demonstrate exceptional efficacy against various grass and broadleaf weeds. Specifically, it controls wild oat and crabgrass more effectively than older standards. Additionally, its systemic movement ensures the chemical reaches all parts of the weed. This efficacy makes it a valuable asset for integrated weed management programs. Integrated strategies will likely include this molecule to prevent further resistance development in heavy agricultural regions.
This herbicide inhibits the PPO enzyme, which stops chlorophyll production in weeds and leads to the accumulation of reactive oxygen species that destroy plant tissue.
Yes, greenhouse and field studies indicate that fendioxypyracil has higher potency, particularly against the PPO2 isoform found in many resistant weed species.
Unlike many contact PPO inhibitors, fendioxypyracil demonstrates systemic activity, meaning it travels through the vascular system of the weed for more comprehensive control.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Seiser T et al. Fendioxypyracil, a new and systemic PPO-inhibiting herbicide for X-spectrum weed control. Pest Manag Sci. 2026 Mar 28. doi: 10.1002/ps.70763. PMID: 41902588.
ChemRobotics. Patented New ISO Name Approved – June 2025: Fendioxypyracil, a New Herbicide Compound By BASF SE. News & Updates. 2025 Jun 26.
Dayan FE, Duke SO. Chapter 81 - Protoporphyrinogen Oxidase-Inhibiting Herbicides. In: Krieger R, editor. Hayes' Handbook of Pesticide Toxicology (Third Edition). Academic Press; 2010. p. 1733-51.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Fendioxypyracil is a new systemic herbicide targeting the PPO enzyme to control resistant weeds, providing a potent alternative for integrated farm manageme...
5 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
